July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Prevalence and associated factors of diabetic retinopathy in a Russian Population. The Ural Eye and Medical Study
Author Affiliations & Notes
  • Mukharram Bikbov
    Ufa Eye Research Institute, Ufa, Russian Federation
  • Timur Gilmanshin
    Ufa Eye Research Institute, Ufa, Russian Federation
  • Rinat Zainullin
    Ufa Eye Research Institute, Ufa, Russian Federation
  • Gyulli Kazakbaeva
    Ufa Eye Research Institute, Ufa, Russian Federation
  • Ellina Rakhimova
    Ufa Eye Research Institute, Ufa, Russian Federation
  • Kamilla Safiullina
    Ufa Eye Research Institute, Ufa, Russian Federation
  • Songhomitra Panda-Jonas
    Department of Ophthalmology, Medical Faculty Mannheim of the Ruprecht-Karls-University of Heidelberg, Mannheim, Germany
  • Iulia Rusakova
    Ufa Eye Research Institute, Ufa, Russian Federation
  • Natalia Bolshakova
    Ufa Eye Research Institute, Ufa, Russian Federation
  • Guzel Bikbova
    Ufa Eye Research Institute, Ufa, Russian Federation
  • Jost B Jonas
    Department of Ophthalmology, Medical Faculty Mannheim of the Ruprecht-Karls-University of Heidelberg, Mannheim, Germany
  • Footnotes
    Commercial Relationships   Mukharram Bikbov, None; Timur Gilmanshin, None; Rinat Zainullin, None; Gyulli Kazakbaeva, None; Ellina Rakhimova, None; Kamilla Safiullina, None; Songhomitra Panda-Jonas, None; Iulia Rusakova, None; Natalia Bolshakova, None; Guzel Bikbova, None; Jost Jonas, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 3959. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mukharram Bikbov, Timur Gilmanshin, Rinat Zainullin, Gyulli Kazakbaeva, Ellina Rakhimova, Kamilla Safiullina, Songhomitra Panda-Jonas, Iulia Rusakova, Natalia Bolshakova, Guzel Bikbova, Jost B Jonas; Prevalence and associated factors of diabetic retinopathy in a Russian Population. The Ural Eye and Medical Study. Invest. Ophthalmol. Vis. Sci. 2019;60(9):3959. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To assess the prevalence and associated factors of diabetic retinopathy in a Russian population.

Methods : The Ural Eye and Medical Study (UEMS) is a population-based study performed in the city of Ufa/Russia and in villages in a distance of 65 km from Ufa. The inclusion criterion was an age of 40+ years. Diabetic retinopathy was diagnosed on fundus photographs.

Results : Out of a population of 7328 eligible individuals, 5899 individuals (2580 (43.7%) men) (participation rate:80.5%) participated (mean age:59.0±10.7 years (range:40-94 years)). Assessable fundus photographs were available for 4900 (83.1%) participants. Diabetic retinopathy was detected in 101/4900 individuals or 2.1% (95% confidence interval (CI): 1.7, 2.5). In binary multivariable analysis, a higher prevalence of diabetic retinopathy was associated with older age (P<0.006; odds ratio (OR): 1.05; 95%CI: 1.02,1.07), higher glucose serum concentration (P<0.001;OR: 1.17; 95%CI:1.09,1.25), history of therapy with insulin (P<0.001;OR: 3.09; 95%CI:3.08,4.94), higher systolic blood pressure (P<0.001;OR: 1.03; 95%CI:1.01,1.04), and longer history of known diabetes (P<0.001;OR: 1.06; 95%CI:1.03,1.09). In that model, diabetic retinopathy prevalence was not associated with axial length (P=0.71), rural versus urban region of habitation (P=0.08), and serum concentration of triglycerides (P=0.26).

Conclusions : In this typical, ethnically mixed, urban and rural Russian population aged 40+ years, the prevalence of diabetic retinopathy was relatively low (101/4900 or 2.1% (95%:1.7, 2.5) and depended on known risk factors such as higher systolic blood pressure, longer duration of known diabetes, older age and worse metabolic control.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×